Press "Enter" to skip to content

Study identifies potential drug target for prostate cancer

A new study has identified a drug target to prevent the growth and progression of prostate cancer. Uncovering a specific novel non-coding RNA, the researchers believe that the discovery could lead to new biomarkers of prostate cancer and more effective …Read more





Study identifies potential drug target for prostate cancer

Researchers have discovered a non-coding RNA which could be used as a biomarker and in new therapies for prostate cancer A new study has identified a drug target to prevent the growth and progression of prostate cancer Uncovering a specific novel non
Read more

Researchers identify key to controlling growth and progression of prostate cancer

Gioelis discovery identifies HULLK as a potential target patients prostate cancer is prior to treatment This could prove extremely useful for men who are weighing the pros and cons of their treatment options There is still a lot of research
Read more

Comprehensive Genetic Profiling Unravels Molecular Targets in Prostate Cancer

To inform targeted therapy options and also identify targets for the development and investigators pursuing drug discovery for patients with advanced prostate cancer Agarwal said noting that the study was not possible to conduct prior to the
Read more

Biomarker Analysis Paves the Way for Targeted Therapies in Prostate Cancer

Comprehensive genomic profiling for prostate cancer is gaining traction as a tool to inform treatment plans A new study has identified targetable there is a molecular target that is targetable by a drug either currently available in the clinic
Read more

Discovery of Mechanism behind Precision Cancer Drug Opens Door for More Targeted Treatment

New research cancer prostate cancer and pancreatic cancer and are part of an approach known as precision medicine which targets treatments based on genetic environmental and lifestyle factors What weve done is identify how the drugs work
Read more

New Immune Data from Ongoing ADXS-NEO Phase 1 Study Support Clinical Potential for Neoantigen-Directed Immunotherapies

Part A of the study is open to patients with metastatic non and generating or maintaining CD8 T cell activity against these targets may increase the potential for killing cancer cells All of the first four patients in this Phase 1 trial had a hotspot
Read more

Please follow and like us:

Comments are closed.